Scottish Health Innovations Ltd (SHIL) works in partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. Registered Number: SC 236303. Registered address: The Golden Jubliee National Hospital, Fourth Floor East, Agmemmon St, Clydebank, G81 4DY
News & Events
Stay up to date with latest activity at SHIL
Spin-out Ambicare Health highlighted as emerging player in global skin market analysis
Ambicare Health, a 2004 spin-out from NHS Tayside, University of St Andrews and Scottish Health Innovations Ltd has been highlighted as an emerging international player in the latest research study on Global Skin Diagnostic Equipment Market.
Published by Advanced Market Analytics (AMA), the Global Skin Diagnostic Equipment Market research report shows the latest market insights with upcoming trends and breakdown of the products and services; plus information on emerging players.
Ambicare Health Ltd has developed a portfolio of wearable light sources for medical and consumer healthcare applications, led by Professor Ifor Samuel, PhD in Physics from Cambridge and Founder of the Organic Semiconductor Centre at University of St Andrews, and Professor James Ferguson, Consultant Dermatologist at Ninewells Hospital in NHS Tayside.
Ambicare has developed two distinct product lines - Ambulight PDT and LUSTRE ClearSkin both clinically proven and convenient to use for the treatment of specific dermatological conditions - non-melanoma skin cancer and acne. Ambicare’s patented platform technology allows the user to ‘wear’ the light delivery device, enabling the treatment to be delivered safely and conveniently. The patented mechanism delivers improved end results through consistency of the light delivery to the skin.
The entire range of LUSTRE products are CE certified indicating conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). LUSTRE has also been awarded clearance by the US Food and Drug Administration (FDA) for the over-the-counter sale of its LUSTRE ClearSkin system for the treatment of mild to moderate acne, spots and pimples.
The company also featured this year on the BBC’s The Customer is Always Right; and more recently, have been supporting NHS staff suffering from PPE-related skin breakouts, commonly referred to as ‘maskne’.